Literature DB >> 10957822

Evaluation of inpatient dialectical-behavioral therapy for borderline personality disorder--a prospective study.

M Bohus1, B Haaf, C Stiglmayr, U Pohl, R Böhme, M Linehan.   

Abstract

Dialectical-Behavioral Therapy for Borderline Personality Disorder (DBT) developed by M. Linehan is specifically designed for the outpatient treatment of chronically suicidal patients with borderline personality disorder. Research on DBT therapy, its course and its results has focused to date on treatments in an outpatient setting. Hypothesizing that the course of therapy could be accelerated and improved by an inpatient setting at the beginning of outpatient DBT, we developed a treatment program of inpatient therapy for this patient group according to the guidelines of DBT. It consists of a three-month inpatient treatment prior to long-term outpatient therapy. In this pilot study 24 female patients were compared at admission to the hospital, and at one month after discharge with respect to psychopathology and frequency of self-injuries. Significant improvements in ratings of depression, dissociation, anxiety and global stress were found. A highly significant decrease in the number of parasuicidal acts was also reported. Analysis of the average effect sizes shows a strong effect which prompts the development of a randomized controlled design.

Entities:  

Mesh:

Year:  2000        PMID: 10957822     DOI: 10.1016/s0005-7967(99)00103-5

Source DB:  PubMed          Journal:  Behav Res Ther        ISSN: 0005-7967


  19 in total

Review 1.  Dialectical behavior therapy for personality disorders.

Authors:  S L Rizvi; M M Linehan
Journal:  Curr Psychiatry Rep       Date:  2001-02       Impact factor: 5.285

2.  Utilization of evidenced based dialectical behavioral therapy in assertive community treatment: examining feasibility and challenges.

Authors:  Tracee Burroughs; Jacqueline Somerville
Journal:  Community Ment Health J       Date:  2012-02-14

3.  [Self inflicting behavior in patients with borderline personality disorder : retrospective analysis of principles of plastic surgery therapy].

Authors:  F Stang; S Rudolf; F Siemers; T Namdar; T Lange; P Mailänder
Journal:  Chirurg       Date:  2011-05       Impact factor: 0.955

Review 4.  The effectiveness of cognitive behavioral therapy for personality disorders.

Authors:  Alexis K Matusiewicz; Christopher J Hopwood; Annie N Banducci; C W Lejuez
Journal:  Psychiatr Clin North Am       Date:  2010-09

Review 5.  Management of borderline personality disorder.

Authors:  Robert S Biskin; Joel Paris
Journal:  CMAJ       Date:  2012-10-01       Impact factor: 8.262

Review 6.  Dialectical behavior therapy for adolescents: theory, treatment adaptations, and empirical outcomes.

Authors:  Heather A MacPherson; Jennifer S Cheavens; Mary A Fristad
Journal:  Clin Child Fam Psychol Rev       Date:  2013-03

Review 7.  Methodological considerations treatment trials for persons personality disorder.

Authors:  Mary C Zanarini; Barbara Stanley; Donald W Black; John C Markowitz; Marianne Goodman; Paul Pilkonis; Thomas R Lynch; Kenneth Levy; Peter Fonagy; Martin Bohus; Joan Farrell; Charles Sanislow
Journal:  Ann Clin Psychiatry       Date:  2010-05       Impact factor: 1.567

Review 8.  The application of dialectical behavior therapy for patients with borderline personality disorder on inpatient units.

Authors:  C R Swenson; C Sanderson; R A Dulit; M M Linehan
Journal:  Psychiatr Q       Date:  2001

9.  Assessing the marks of change: how psychotherapy alters the brain structure in women with borderline personality disorder.

Authors:  Falk Mancke; Ruth Schmitt; Dorina Winter; Inga Niedtfeld; Sabine C Herpertz; Christian Schmahl
Journal:  J Psychiatry Neurosci       Date:  2018-05       Impact factor: 6.186

10.  Neural correlates of distraction in borderline personality disorder before and after dialectical behavior therapy.

Authors:  Dorina Winter; Inga Niedtfeld; Ruth Schmitt; Martin Bohus; Christian Schmahl; Sabine C Herpertz
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-04-18       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.